Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the ATR Kinase Inhibitor ART0380 Administered Orally as Monotherapy...


Collapse Overview 
Collapse sponsor award id
UAMS C24914


Collapse Biography 

Collapse Time 
Collapse start date
2022-05-13

Collapse end date
2023-05-12